I wouldn't say you're smart, Meerkat. AT least you lack the smarts to evaluate a clinical trial.
In the last two dosing cohorts, 4 of the 6 patients have shown stable disease. That's 66%. If the last patient of the 4th cohort also shows stable disease, that will be 83%. Or, to look at another way, it will be a 100% success rate of the 4th cohort. And you call that tenuous?
Also, bare in mind that these are very sick patients who have not responded to other treatments and are in the end stage of their disease. Stable disease is an excellent result and will give them months or possibly years more life with their loved ones. If the cancer isn't progressing, it isn't going to kill them.
- Forums
- ASX - By Stock
- PAB
- ann: data from final cohort of patients
ann: data from final cohort of patients, page-36
-
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1242857 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1004952 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1242857 | 0.007 |
21 | 6303960 | 0.006 |
22 | 8280525 | 0.005 |
10 | 5567451 | 0.004 |
8 | 6400016 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1004952 | 2 |
0.009 | 1766604 | 3 |
0.010 | 1412000 | 3 |
0.011 | 1080000 | 2 |
0.012 | 1558283 | 5 |
Last trade - 10.06am 24/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online